logo inner

Director, Market Access DACH


Cytokinetics is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which cardiac muscle performance is compromised. As a leader in muscle biology and the mechanics of muscle performance, the company is developing small molecule drug candidates specifically engineered to impact myocardial muscle function and contractility.
Reporting directly to the VP, General Manager, DACH, with a dotted line to the Head of Market Access Europe, and as a member of the DACH Leadership Team, the Director Market Access DACH will lead, plan and execute market access strategy, projects and initiatives in Germany, Austria and Switzerland, both on the national as well as on the regional, operative level. They will lead, coordinate and support the German Field Market Access team in their regional and local customer engagements, as well as collaboration with the commercial sales force.

Ensuring alignment with the International Market Access team, the Market Access Director will be a dynamic and adaptable leader, responsible for implementing strategies and initiatives that enhance commercial success across all business areas in Germany, Austria and Switzerland.

ROLE RESPONSIBILITIES


Market Access and Reimbursement Strategy

  • Support national reimbursement strategies across the DACH region, in close collaboration with the DACH leadership team, the company´s international market access functions, and the external market access consultants of the respective country. Support the development of value propositions, evidence packages and reimbursement submissions for favorable Health Technology Assessment (HTA) outcomes and pricing / reimbursement decisions with bodies such as IQWIG, Gemeinsamer Bundesausschuss (G-BA), GKV-SV (Spitzenverband der gesetzlichen Krankenkassen), on the AMNOG reimbursement process in Germany, as well as related institutions in Austria (Dachverband) and Switzerland (BAG).
  • Pricing responsibilities will include pricing assumptions and scenarios for business review and development for the Regional & Global Pricing Committee, when needed. Oversee and lead the planning and execution of pre-launch and launch market access activities. Drive successful launch readiness activities, including reimbursement and pricing negotiations with key regional stakeholders of the respective countries.
  • Ensure pipeline products are appropriately included in country level horizon scanning processes.
  • Develop and execute regional reimbursement strategies and innovative contracting approaches.
  • Monitor and analyze national as well as regional healthcare developments, including cost-effectiveness, reimbursement pathways, early benefit assessments or changes in pharmaceutical funding or purchasing mechanisms. Report trends and adapt strategies, accordingly, in order to minimize price reductions or price reference range .
  • Provide proactive insights and training to commercial team, on strategies to reduce prescription hurdles and enhance product uptake.

Lead and Develop Teams

  • The Director Market Access DACH will inspirationally lead the Field Market Access function in Germany, ensuring effective execution of regional access strategies across the 17 KV regions. This includes leading, instructing and training a team of Field Market Access Managers who engage with Commercial Key Account Managers, prescribers, regional payers, healthcare providers, and other key stakeholders to facilitate optimal reimbursement and access conditions for Cytokinetic´s products. The operative support of the Key Account Managers in the field via double visits of important prescribers will be particularly important to address any reimbursement concerns that limit the use of Cytokinetic´s products.
  • Lead, coach, and develop a high-performing team of Field Market Access Managers across Germany.
  • Provide ongoing training and development for the Field Market Access team and other customer-facing roles to ensure excellence in execution and stakeholder engagement.

Stakeholder Engagement and Communication

  • Establish and maintain trusted relationships with key opinion leaders (KOLs), sick funds, Regional Associations of SHI Physicians (KVen), regional payor bodies and other relevant stakeholders and decision makers across the DACH region.
  • Understand and address stakeholder needs to support the adoption of innovative therapies.
  • Represent the company in relevant industry associations, forums, and regional events of payers and policy makers.
  • Ensure compliant engagement with external stakeholders, offering value-added services and addressing access barriers.
  • Enhance the company’s reputation by positioning it as a trusted partner within the healthcare ecosystem in the DACH region.

Cross-functional Collaboration

  • Collaborate closely with national marketing, medical, sales teams, as well as international market access and HEOR functions, to ensure cohesive strategy execution.
  • Support driving a Key Account Management strategy approach to the markets by integrating market access perspectives into cross-functional customer engagement plans.
  • Facilitate communication and alignment between field and office-based teams.
  • Manage local market access budgets and allocate resources effectively to meet strategic priorities.

Data-Driven Decision Making

  • Analyze and present data to inform strategic decisions and track performance against KPIs.
  • Identify and communicate market access trends, opportunities, and risks to internal stakeholders.

Communication and Enablement

  • Create and deliver needs-oriented information materials that highlight the value of products and support effective communication with prescribers.
  • Utilize both analog and digital channels to engage with networks and stakeholders effectively.

QUALIFICATIONS AND EXPERIENCE


Educational Background

  • Bachelor's degree required; advanced university degree preferred, ideally in natural science, business administration, or healthcare-related field.

Industry Experience

  • 10+ years of experience in the pharmaceutical or biopharmaceutical industry within market access-related functions.
  • Minimum of 3 years in regional market access or related roles, with demonstrated success in execution of market access strategies in the field on customer level.

Healthcare System Expertise

  • Deep understanding of the German, and basic understanding of the Austrian and Swiss healthcare systems, including legal frameworks for pricing and reimbursement.
  • Strong network and stakeholder engagement experience with sick funds and other payor bodies in Germany. Operative experience in Austria and Switzerland is not a must, but beneficial.

Stakeholder Management and Communication

  • Proven experience in stakeholder management, with the ability to build resilient networks and influence decision-making.
  • Strong communication and presentation skills, capable of translating complex topics into audience-appropriate formats.
  • High motivation, goal orientation, and a team-oriented, independent working style.

Cross-functional and Digital Competence

  • Experience in matrixed, fast-paced organizations and managing cross-functional projects.
  • IT-savvy, with proficiency in modern digital communication channels and MS Office applications.

Language and Travel

  • Native-level fluency in German and business-fluent English, both written and verbal.
  • Willingness to travel regularly across the DACH region.

What We Offer


  • The privilege to participate in building and shaping the in-country operations of a young, dynamic company in the DACH region, assuming personal responsibility for business-critical projects and processes within a team of highly experienced professionals.
  • An opportunity to join a scientifically outstanding, research-based specialty care pharmaceutical company, shaping the future of innovative treatments in muscle biology.
  • A highly collaborative and inclusive environment which supports professional growth and personal development.
  • A very competitive salary and benefits package above industry average.

Our employees come from different backgrounds, and we celebrate those differences. We are looking for the best candidates for our open roles, but do not expect applicants to meet every qualification in order to be considered. If you are excited about what you could accomplish at Cytokinetics and believe you can add value to our team, we would love to hear from you.

Please review our General Data Protection Regulation (GDPR) policy PRIOR to applying.  


Our passion is anchored in robust scientific thinking, grounded in integrity and critical thinking. We keep the patient front and center in all we do – all actions and decisions are in service of the patient and their caregivers. We champion integrity, ethics, doing the right thing, and being our best selves.

Fraud Warning: How to Identify Impersonated Cytokinetics Job Postings and Offers


Recently, there have been fraudulent employment offers being sent to candidates on behalf of Cytokinetics. Please be advised that all legitimate offers from Cytokinetics will come directly from our official email domain (Cytokinetics.com) and will only be made after completing a formal interview process.Here are some ways to check for authenticity:

  • We do not conduct job interviews through non-standard text messaging applications
  • We will never request personal information such as banking details until after an official offer has been accepted and verified
  • We will never request that you purchase equipment or other items when interviewing or hiring
  • If you are unsure about the authenticity of an offer, or if you receive any suspicious communication, please contact us directly at talentacquisition@cytokinetics.com

Please visit our website at: www.cytokinetics.com


Cytokinetics is an Equal Opportunity Employer



Life at Cytokinetics

We are a leading biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule drugs that specifically target the cytoskeleton. The cytoskeleton is a complex biological infrastructure that plays a fundamental role within every human cell. A number of commonly used drugs and a growing body of research validate the role that the cytoskeleton plays in a wide array of human diseases. Our focus on the cytoskeleton enables us to develop novel and potentially safer and more effective classes of drugs directed at treatments for cancer, cardiovascular disease, fungal diseases and other diseases. We have developed a cell biology driven approach and proprietary technologies to evaluate the function of many interacting proteins in the complex environment of the intact human cell. We believe that our approach enhances the speed, efficiency and yield of our drug discovery and development process by accurately and rapidly identifying drug candidates with attractive properties. Our approach has yielded two drug candidates for the treatment of cancer, a drug candidate for the treatment of acute congestive heart failure and more than ten other research programs. Our most advanced drug candidate, SB-715992, is the subject of a broad Phase II clinical trials program designed to evaluate its effectiveness in many different types of cancer. An investigational new drug application, or IND, was filed with the U.S. Food and Drug Administration, or FDA, in 2003 for our second cancer drug candidate, SB-743921, which we expect will enter Phase I clinical development in early 2004. SB-715992 and SB-743921 are being developed through our strategic alliance with GlaxoSmithKline. In addition, we expect to initiate Phase I clinical development for a drug candidate, CK-1213296, for the treatment of acute congestive heart failure in the second half of 2004.
Thrive Here & What We Value1. Passionate about robust scientific thinking grounded in integrity and critical thinking2. Celebrates differences among employees3. Patient-centric approach to all actions and decisions4. Values integrity, ethics, doing the right thing, and being our best selves5. Emphasis on patient-centered care6. Focus on innovation and continuous improvement7. Dedicated to keeping the patient front and center in all actions and decisions8. Values-driven and sustainable approach to drug discovery and development9. Rigorous scientific thinking and critical thinking10. Emphasis on collaboration across different departments and teams
Your tracker settings

We use cookies and similar methods to recognize visitors and remember their preferences. We also use them to measure ad campaign effectiveness, target ads and analyze site traffic. To learn more about these methods, including how to disable them, view our Cookie Policy or Privacy Policy.

By tapping `Accept`, you consent to the use of these methods by us and third parties. You can always change your tracker preferences by visiting our Cookie Policy.

logo innerThatStartupJob
Discover the best startup and their job positions, all in one place.
Copyright © 2025